Mode
Text Size
Log in / Sign up

Vestibular migraine

Part of Migraine

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for vestibular migraine

3 trials tracked for vestibular migraine: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 11 citations.

3Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 2 1 Other / NA 1
  1. Phase 3 Rizatriptan for Episodic Dizziness in Vestibular Migraine Completed · 11 cited
  2. Phase 2 Galcanezumab for Vestibular Migraine Completed
  3. N/A Effects of Lifestyle Modification on Vestibular Migraine Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Migraine

Related studies from across the Migraine family.

Probiotics provide the largest reduction in migraine frequency among analyzed nutritional supplements
Neurology Meta-analysis
Probiotics provide the largest reduction in migraine frequency among analyzed nutritional supplements Probiotics and Coenzyme Q10 Show Promise for Migraine Frequency
This network meta-analysis of 791 adult migraineurs evaluated vitamins, magnesium, coenzyme Q10, and probiotics. Probiotics showed the large…
New analysis shows that probiotics and coenzyme Q10 may reduce how often migraines occur, while magnesium specifically helps lower pain seve…
Sumatriptan/naproxen sodium and ibuprofen show significant pain freedom for pediatric migraine treatment
Drug Pipeline Meta-analysis
Sumatriptan/naproxen sodium and ibuprofen show significant pain freedom for pediatric migraine treatment New analysis shows effective migraine treatments for children and adolescents
This network meta-analysis of 30 studies involving 8,914 participants evaluated acute migraine medications in children and adolescents. Suma…
A large review of 30 studies helps identify which medications provide the fastest relief from migraines in children and teenagers.
Propranolol shows potential for managing various neurological diseases including PTSD, migraine, and autism spectrum disorder
Psychiatry Sys. Review
Propranolol shows potential for managing various neurological diseases including PTSD, migraine, and autism spectrum disorder Propranolol Shows Promise for Brain Conditions
This systematic review synthesizes clinical and preclinical evidence regarding the effects of propranolol on several neurological conditions…
A new review suggests propranolol, a common blood pressure drug, may help with PTSD, autism, and more. Here's what it means.
Non-invasive vagus nerve stimulation reduces monthly headache days in migraine patients
Nephrology Meta-analysis
Non-invasive vagus nerve stimulation reduces monthly headache days in migraine patients Trial Shows Vagus Nerve Stimulation Reduces Migraine Frequency
This meta-analysis of 917 patients with migraine found that non-invasive vagus nerve stimulation (nVNS) significantly reduced monthly headac…
Non-invasive vagus nerve stimulation may reduce the number of monthly headache days and the need for acute medication for people living with…
Transcutaneous Vagus Nerve Stimulation utilizes distinct auricular and cervical pathways for non-invasive treatment applications
Neurology Sys. Review
Transcutaneous Vagus Nerve Stimulation utilizes distinct auricular and cervical pathways for non-invasive treatment applications Two different ways to stimulate the vagus nerve for treatment
This narrative review examines the anatomical access points and methodologies for transcutaneous Vagus Nerve Stimulation (tVNS). It distingu…
New research highlights two distinct paths for non-invasive nerve stimulation to treat conditions like migraine and depression.
30% of pediatric patients with migraine report at least one adverse event during pharmacological prophylaxis
Pediatrics Meta-analysis
30% of pediatric patients with migraine report at least one adverse event during pharmacological prophylaxis Trial Shows Specific Side Effects for Children with Migraine
This meta-analysis of 2742 patients evaluates the safety profile of various pharmacological migraine prophylaxis treatments in children and …
About 30% of children and adolescents taking migraine prevention medication report experiencing at least one side effect during treatment.
Migraine patients may have an increased risk of neovascular age-related macular degeneration
Neurology Sys. Review
Migraine patients may have an increased risk of neovascular age-related macular degeneration Migraine patients may face higher risk of certain eye conditions
This narrative review examines the association between migraine and various retinal conditions, including retinal migraine and AMD. The auth…
New research highlights a link between migraines and age-related macular degeneration, potentially impacting long-term vision for many suffe…
Endometriosis genetic risk score tied to pain, cardiometabolic conditions in both sexes
Genetics & Precision Medicine Meta-analysis
Endometriosis genetic risk score tied to pain, cardiometabolic conditions in both sexes Genetic Risk for Endometriosis Linked to Chronic Pain Conditions
This meta-analysis links an endometriosis polygenic risk score (PRS) to 20 of 29 comorbidities in women and to pain and cardiometabolic cond…
A large genetic study reveals that the same genetic markers linked to endometriosis are also associated with fibromyalgia, migraine, and bac…
Post-marketing data on CGRP inhibitors show paucity of data and additional risks from chronic biologic use
Drug Pipeline Sys. Review
Post-marketing data on CGRP inhibitors show paucity of data and additional risks from chronic biologic use Post-marketing review highlights safety gaps for migraine CGRP drugs
This narrative review examines monoclonal antibodies and Calcitonin Gene-Related Peptide (CGRP) inhibitors for migraine in the post-marketin…
A review of migraine treatments notes limited data on long-term risks for CGRP inhibitors, urging caution during active monitoring.
Asia-Pacific experts reach consensus on migraine management and anti-CGRP mAb use in adolescents
Neurology Guideline
Asia-Pacific experts reach consensus on migraine management and anti-CGRP mAb use in adolescents Asia-Pacific experts find consensus on migraine diagnosis and treatment
This guideline presents a Delphi consensus involving 14 headache specialists from seven Asia-Pacific countries. The group evaluated statemen…
Headache specialists across Asia-Pacific agree on key migraine diagnosis and treatment steps, favoring anti-CGRP drugs for most patients but…
Bayesian network meta-analysis compares CGRP therapies for episodic migraine
Neurology Meta-analysis
Bayesian network meta-analysis compares CGRP therapies for episodic migraine New migraine drugs show big benefits over placebo for monthly attack counts
This Bayesian network meta-analysis synthesized evidence on six CGRP-targeted therapies for episodic migraine. It found that monoclonal anti…
New migraine drugs cut monthly attacks more than placebo, with injectables slightly better than pills for some people.
Narrative review refutes causal link between endometriosis and migraine
Neurology Sys. Review
Narrative review refutes causal link between endometriosis and migraine Endometriosis and Migraine Share Hidden Genetic Roots
This narrative review examines the association between endometriosis and migraine. The authors refute a causal relationship and discuss shar…
New genetic research suggests endometriosis and migraine are parallel conditions driven by shared inflammatory pathways, not just hormones.